Amino
Amino Health, now Judi Care, offers a data-driven healthcare navigation platform to help members find high-quality, affordable providers.
Secondary Market Price
How Amino Measures Up
To help you manage your Amino equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series C
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Amino's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Amino Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Amino's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Founded in 2013 as Amino Health, the company operates a data-driven healthcare guidance platform. It processes medical claims data to provide users with recommendations for physical and mental health care, encounter-level cost estimates, and proprietary quality ratings. The platform is designed to help members of health plans navigate their benefits and find in-network providers. Amino Health, which has raised $45 million in total funding, collaborates with health plans, third-party administrators (TPAs), and benefits platforms. In 2025, the company was acquired by Capital Rx and rebranded as Judi Care, becoming part of the broader Judi Health platform.
Following its acquisition and rebrand in 2025, the company completed a Series F fundraise and integrated a dynamic co-pay product into its technology stack. For the fourth consecutive year, the company was named a Deloitte Technology Fast 500 winner, ranking #136 in 2025. In January 2026, its parent organization, Capital Rx, announced it had surpassed five million contracted employer lives. Future efforts are indicated to focus on the continued development of its unified claims processing and care navigation technology.
- GV (formerly Google Ventures)
- Venrock
- Union Square Ventures
- Box Group
- Time Warner Investments
- Goodwater Capital
- Hearst Ventures
- Co-Founder, Ben Anderson
- Co-Founder, Yin Wang
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Amino worth joining?
Evaluating an offer from a private company like Amino requires a careful analysis of its equity compensation. Tools like Prospect can help you project the potential future value of your stock options and make a more informed decision.
What should I do with my Amino stock?
The right strategy for your Amino stock depends on your personal financial goals, risk tolerance, and tax situation. Platforms like Prospect offer customized guidance on whether to exercise options, hold, or sell your shares to maximize returns.
Can you sell Amino stock?
As Amino is a private company, you can typically sell shares during specific liquidity events like tender offers or on secondary markets. Navigating these sales to optimize taxes and timing can be complex, but resources like Prospect provide tools to help you decide how much to sell.
How can I find the value of my Amino stock?
The value of private stock like Amino's is determined by its 409A valuation, but its future worth can be difficult to predict. To get a more comprehensive forecast, you can use platforms like Prospect, which use predictive models to project your equity's potential value.
What is Amino's equity worth?
The precise worth of a private company's equity is not public information and fluctuates based on performance, funding, and market conditions. You can use specialized tools from platforms like Prospect to get a data-driven projection of your Amino equity's potential range of outcomes.
What is Amino's stock ticker symbol?
As a private company, Amino does not have a stock ticker symbol because its shares are not traded on a public stock exchange. A ticker symbol will only be assigned if and when the company completes an Initial Public Offering (IPO).
Can I buy or sell Amino stock?
Employees can typically "buy" stock by exercising their vested options, and opportunities to "sell" arise during secondary sales or tender offers. Platforms like Prospect provide tools and strategies for both exercising and selling shares in a tax-optimal way.
What is the criteria to buy or invest in Amino stock?
Investing in a private company like Amino is typically restricted to employees receiving equity compensation or accredited investors participating in organized funding rounds. The general public cannot buy shares as they would with a publicly traded company.
